Prevnar

vaccine diversity flu covid shot needle
Biotech

Vaxcyte surges on 'stunning' 31-valent PCV win against Pfizer

Vaxcyte unveiled what analysts called “stunning” phase 1/2 data for its 31-valent pneumococcal vaccine candidate.
Angus Liu Sep 3, 2024 10:32am
Photo of a syringe and two vials labeled pneumococcal vaccine

Merck compares pneumococcal vaccine to 1983 warhorse

Apr 29, 2024 9:00am
showdown clash versus vs crash lightning fight dispute

Merck strides onto Pfizer’s turf with pivotal vaccine data

Nov 28, 2023 8:20am
Vaccine

Merck's next-gen pneumococcal vaccine receives breakthrough tag

Apr 14, 2022 9:35am
Vaccine

Affinivax nabs huge $226M funding round

Jan 8, 2021 8:35am